Rivastigmine 13.3mg/24hours transdermal patches
BNF presentation 0411000E0AAAIAI within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0411000E0AAAIAI
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
5,429
NHS spend (£)
£400,020.20
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 790 |
| February 2025 | 10 |
| December 2024 | 195 |
| November 2024 | 865 |
| October 2024 | 889 |
| September 2024 | 5 |
| August 2024 | 59 |
| July 2024 | 931 |
| May 2024 | 184 |
| July 2021 | 222 |
| June 2021 | 175 |
| December 2020 | 508 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 33 | No data available |
| Unknown pharmacy | 23 | No data available |
| Unknown pharmacy | 20 | No data available |
| Unknown pharmacy | 20 | No data available |
| Unknown pharmacy | 20 | No data available |
| Unknown pharmacy | 19 | No data available |
| Unknown pharmacy | 18 | No data available |
| Unknown pharmacy | 17 | No data available |
| Unknown pharmacy | 17 | No data available |
| Unknown pharmacy | 16 | No data available |